Tyra Biosciences, Inc. (TYRA)
38.18
+0.13
(+0.34%)
USD |
NASDAQ |
Mar 19, 16:00
38.16
-0.02
(-0.05%)
After-Hours: 20:00
Tyra Biosciences Total Liabilities (Quarterly) : 24.87M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 62.54M |
| Agios Pharmaceuticals, Inc. | 104.11M |
| BridgeBio Pharma, Inc. | 3.013B |
| Nuvalent, Inc. | 164.37M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 284.05M |
| Shareholders Equity (Quarterly) | 259.18M |
| Debt to Equity Ratio | 0.0224 |
| Current Ratio | 14.67 |
| Net Debt Paydown Yield | 0.01% |